PRESS RELEASE published on 04/26/2023 at 06:58, 2 years 7 months ago Vonovia SE to Sell €1.0bn Minority Equity Participation in “Südewo” at around Fair Value
PRESS RELEASE published on 04/26/2023 at 06:57, 2 years 7 months ago EQS-Adhoc: Vonovia SE Agrees to Sell €1.0bn Minority Common Equity Participation in its “Südewo” portfolio.
PRESS RELEASE published on 03/16/2023 at 18:03, 2 years 8 months ago Vonovia SE: Vonovia’s economic development is robust and adapting to changes in its general environment
PRESS RELEASE published on 03/16/2023 at 18:00, 2 years 8 months ago EQS-Adhoc: Vonovia SE: Dividend proposal
PRESS RELEASE published on 03/07/2023 at 18:48, 2 years 8 months ago Vonovia SE: Vonovia initiates independent investigation and will press charges against suspects
PRESS RELEASE published on 01/24/2023 at 09:01, 2 years 10 months ago Vonovia SE: Vonovia invests in Gropyus
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 56 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
